OXON RWE Alzheimer’s Research in 2024 Lancet Report
OXON Real-World Evidence Alzheimer’s Research in 2024 Lancet Report We are excited to announce that OXON’s Real-World Evidence (RWE) Alzheimer’s research has been prominently cited in the 2024 Lancet Commission on Dementia Report. This prestigious recognition underscores our commitment to advancing Alzheimer’s research and improving patient outcomes through evidence-based insights. Significant Contribution The Lancet Commission…
Read more